Table 1 Baseline characteristics of evaluable participants

Female n (%)

48 (87.3)

49 (86.0)

Age y (SD)

40.4 (13.39)

36.4 (11.14)

BMI (SD)

23.16 (3.57)

23.17 (3.55)

Migraine type

  With aura n (%)

22 (40.0)

16 (28.1)

  Without aura n (%)

28 (50.9)

37 (64.9)

Previous migraine prevention

  Participants with no previous preventions n (%)

40 (72.7)

36 (63.2)

  Participants with 1-3 previous preventions n (%)

12 (21.8)

20 (35.0)

  Participants with more than 3 previous preventions n (%)

3 (5.4)

1 (1.8)

Medical history, diseases n (%)

43 (42.1)

59 (57.8)

Concomitant medication n (%)

24 (36.3)

42 (63.6)